Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestasis. 2021

Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, College of Food and Biological Engineering, Hefei University of Technology, Hefei, China. xiaoxiaoyang@hfut.edu.cn.

Cholestasis can induce liver fibrosis and cirrhosis. Apigenin has anti-oxidant and anti-inflammatory effects. Herein, we determined whether apigenin can protect mice against cholestasis. In vitro, apigenin protected TFK-1 cells (a human bile duct cancer cell line) against H2O2-induced ROS generation and inhibited transforming growth factor-β-activated collagen type 1 alpha 1 and α-smooth muscle actin in LX2 cells (a human hepatic stellate cell line). In vivo, cholestatic mice induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) were treated with apigenin. Apigenin potently blocked DDC-induced gallbladder atrophy and associated liver injury, fibrosis and collagen accumulation. Moreover, apigenin relieved the DDC-caused abnormality of bile acid metabolism and restored the balance between bile secretion and excretion by regulating the farnesoid X receptor signaling pathway. Furthermore, apigenin reduced inflammation or oxidative stress in the liver by blocking the DDC-activated Toll-like receptor 4, nuclear factor κB and tumor necrosis factor α, or DDC-suppressed superoxidase dismutase 1/2, catalase and glutathione peroxidase. Taken together, apigenin improves DDC-induced cholestasis by reducing inflammation and oxidative damage and improving bile acid metabolism, indicating its potential application for cholestasis treatment.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
January 2019, Methods in molecular biology (Clifton, N.J.),
Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
September 1996, Hepatology (Baltimore, Md.),
Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
October 1974, Biochemical pharmacology,
Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
October 2022, Nutrients,
Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
July 1982, Gastroenterology,
Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
January 1973, Enzyme,
Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
August 2011, Journal of pediatric surgery,
Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
August 1987, Journal of hepatology,
Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
May 2021, Journal of pharmaceutical and biomedical analysis,
Shihong Zheng, and Peichang Cao, and Zequn Yin, and Xuerui Wang, and Yuanli Chen, and Maoyun Yu, and Baocai Xu, and Chenzhong Liao, and Yajun Duan, and Shuang Zhang, and Jihong Han, and Xiaoxiao Yang
May 2023, Scientific reports,
Copied contents to your clipboard!